{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:41:04Z","timestamp":1787586064280,"version":"build-2736575974"},"reference-count":263,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["18PTC-19-602325"],"award-info":[{"award-number":["18PTC-19-602325"]}]},{"name":"Italian Ministry of Health","award":["GEENA-Q-19-596282"],"award-info":[{"award-number":["GEENA-Q-19-596282"]}]},{"name":"AIRAlzh Onlus (ANCC-COOP)","award":["18PTC-19-602325"],"award-info":[{"award-number":["18PTC-19-602325"]}]},{"name":"AIRAlzh Onlus (ANCC-COOP)","award":["GEENA-Q-19-596282"],"award-info":[{"award-number":["GEENA-Q-19-596282"]}]},{"name":"Alzheimer\u2019s Association\u2014Part the Cloud: Translational Research Funding for Alzheimer\u2019s Disease","award":["18PTC-19-602325"],"award-info":[{"award-number":["18PTC-19-602325"]}]},{"name":"Alzheimer\u2019s Association\u2014Part the Cloud: Translational Research Funding for Alzheimer\u2019s Disease","award":["GEENA-Q-19-596282"],"award-info":[{"award-number":["GEENA-Q-19-596282"]}]},{"name":"Alzheimer\u2019s Association\u2014GAAIN Exploration to Evaluate Novel Alzheimer\u2019s Queries","award":["18PTC-19-602325"],"award-info":[{"award-number":["18PTC-19-602325"]}]},{"name":"Alzheimer\u2019s Association\u2014GAAIN Exploration to Evaluate Novel Alzheimer\u2019s Queries","award":["GEENA-Q-19-596282"],"award-info":[{"award-number":["GEENA-Q-19-596282"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Migraine is a common neurological disorder impairing the quality of life of patients. The condition requires, as an acute or prophylactic line of intervention, the frequent use of drugs acting on the central nervous system (CNS). The long-term impact of these medications on cognition and neurodegeneration has never been consistently assessed. The paper reviews pharmacological migraine treatments and discusses their biological and clinical effects on the CNS. The different anti-migraine drugs show distinct profiles concerning neurodegeneration and the risk of cognitive deficits. These features should be carefully evaluated when prescribing a pharmacological treatment as many migraineurs are of scholar or working age and their performances may be affected by drug misuse. Thus, a reconsideration of therapy guidelines is warranted. Furthermore, since conflicting results have emerged in the relationship between migraine and dementia, future studies must consider present and past pharmacological regimens as potential confounding factors.<\/jats:p>","DOI":"10.3390\/ijms231911418","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T01:51:49Z","timestamp":1664329909000},"page":"11418","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-5923","authenticated-orcid":false,"given":"Mirella","family":"Russo","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"},{"name":"CAST\u2014Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo A.","family":"De Rosa","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Calisi","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Consoli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Evangelista","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedele","family":"Dono","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"},{"name":"CAST\u2014Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Santilli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9181-4373","authenticated-orcid":false,"given":"Alberto","family":"Granzotto","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"},{"name":"CAST\u2014Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Onofrj","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"},{"name":"CAST\u2014Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-2574","authenticated-orcid":false,"given":"Stefano L.","family":"Sensi","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"},{"name":"CAST\u2014Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"},{"name":"Institute for Mind Impairments and Neurological Disorders-iMIND, University of California, Irvine, Irvine, CA 92697, USA"},{"name":"ITAB\u2014Institute of Advanced Biomedical Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"fcaa097","DOI":"10.1093\/braincomms\/fcaa097","article-title":"The health burden of non-communicable neurological disorders in the USA between 1990 and 2017","volume":"2","author":"Dehghan","year":"2020","journal-title":"Brain Commun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11916-022-01039-5","article-title":"Cognitive Impairment in Primary and Secondary Headache Disorders","volume":"26","author":"Robbins","year":"2022","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000353559","article-title":"Migraine and risk of dementia: A nationwide retrospective cohort study","volume":"41","author":"Chuang","year":"2013","journal-title":"Neuroepidemiology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e14467","DOI":"10.1097\/MD.0000000000014467","article-title":"Increased risk of neurodegenerative dementia in women with migraines: A nested case-control study using a national sample cohort","volume":"98","author":"Lee","year":"2019","journal-title":"Medicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/gps.5180","article-title":"Migraine and the risk of all-cause dementia, Alzheimer\u2019s disease, and vascular dementia: A prospective cohort study in community-dwelling older adults","volume":"34","author":"Morton","year":"2019","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3233\/JAD-190581","article-title":"Association between Migraine Headaches and Dementia in More than 7400 Patients Followed in General Practices in the United Kingdom","volume":"71","author":"Kostev","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7307198","DOI":"10.1155\/2019\/7307198","article-title":"Cognitive Decline in Chronic Migraine with Nonsteroid Anti-inflammation Drug Overuse: A Cross-Sectional Study","volume":"2019","author":"Cai","year":"2019","journal-title":"Pain Res. Manag."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/0333102420916751","article-title":"Effect of genetic liability to migraine on cognition and brain volume: A Mendelian randomization study","volume":"40","author":"Daghlas","year":"2020","journal-title":"Cephalalgia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/head.13794","article-title":"Migraine Headache and Risk of Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study","volume":"60","author":"George","year":"2020","journal-title":"Headache J. Head Face Pain"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1526-4610.2009.01572.x","article-title":"Migraine does not affect cognitive decline: Results from the Maastricht aging study","volume":"50","author":"Baars","year":"2010","journal-title":"Headache"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1526-4610.2000.00124.x","article-title":"Does migraine headache affect cognitive function in the elderly? Report from the Maastricht Aging Study (MAAS)","volume":"40","author":"Jelicic","year":"2000","journal-title":"Headache"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lee, H.-J., Yu, H., Gil Myeong, S., Park, K., and Kim, D.-K. (2021). Mid- and Late-Life Migraine Is Associated with an Increased Risk of All-Cause Dementia and Alzheimer\u2019s Disease, but Not Vascular Dementia: A Nationwide Retrospective Cohort Study. J. Pers. Med., 11.","DOI":"10.3390\/jpm11100990"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s40520-021-02065-w","article-title":"Migraine and the risk of dementia: A meta-analysis and systematic review","volume":"34","author":"Jiang","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_14","first-page":"180","article-title":"Dementia in Europe Yearbook 2019: Estimating the prevalence of dementia in Europe","volume":"2019","author":"Bintener","year":"2019","journal-title":"Alzheimer Eur."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/cjn.2016.38","article-title":"Systematic Reviews and Meta-Analyses of the Incidence and Prevalence of Dementia and Its Commoner Neurodegenerative Causes","volume":"43","author":"Maxwell","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-021-02360-w","article-title":"Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is independently associated with dementia and strongly associated with arteriolosclerosis in the oldest-old","volume":"142","author":"Harrison","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.14153","article-title":"The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice","volume":"61","author":"Ailani","year":"2021","journal-title":"Headache J. Head Face Pain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","article-title":"Diagnosis and management of migraine in ten steps","volume":"17","author":"Eigenbrodt","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10194-012-0437-6","article-title":"Italian guidelines for primary headaches: 2012 revised version","volume":"13","author":"Sarchielli","year":"2012","journal-title":"J. Headache Pain"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s10194-018-0899-2","article-title":"Aids to management of headache disorders in primary care (2nd edition)","volume":"20","author":"Steiner","year":"2019","journal-title":"J. Headache Pain"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1590\/S1980-57642012DN06020002","article-title":"Cognitive impairment in migraine:A systematic review","volume":"6","author":"Barbosa","year":"2012","journal-title":"Dement. Neuropsychol."},{"key":"ref_24","first-page":"3","article-title":"Interictal Cognitive Deficits in Migraine Sufferers: A Meta-Analysis","volume":"1","author":"Braganza","year":"2021","journal-title":"Neuropsychol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s10194-018-0933-4","article-title":"Cognitive dysfunction and migraine","volume":"19","author":"Vuralli","year":"2018","journal-title":"J. Headache Pain"},{"key":"ref_26","first-page":"E137","article-title":"Subjective Cognitive Symptoms During a Migraine Attack: A Prospective Study of a Clinic-Based Sample","volume":"19","author":"Oliveira","year":"2016","journal-title":"Pain Physician"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pneurobio.2011.01.002","article-title":"The effect of pain on cognitive function: A review of clinical and preclinical research","volume":"93","author":"Moriarty","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neulet.2008.05.033","article-title":"Frontal lobe structure and executive function in migraine patients","volume":"440","author":"Schmitz","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1468-2982.2007.01394.x","article-title":"Interictal Executive Dysfunction in Migraineurs without Aura: Relationship with Duration and Intensity of Attacks","volume":"27","author":"Camarda","year":"2007","journal-title":"Cephalalgia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0b013e3182a6cb32","article-title":"Migraine and structural changes in the brain: A systematic review and meta-analysis","volume":"81","author":"Bashir","year":"2013","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/jnnp-2018-318254","article-title":"Migraine and risk of stroke","volume":"91","author":"Kurth","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2013). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia, 33, 629\u2013808.","DOI":"10.1177\/0333102413485658"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0333102413513181","article-title":"Headache as a risk factor for dementia: A prospective population-based study","volume":"34","author":"Hagen","year":"2014","journal-title":"Cephalalgia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ane.13528","article-title":"Meta-analysis of association between migraine and risk of dementia","volume":"145","author":"Wang","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1212\/WNL.0000000000200607","article-title":"Prevalence and Predictors of Vascular Cognitive Impairment in Patients with CADASIL","volume":"99","author":"Jolly","year":"2022","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mito.2017.12.012","article-title":"Cognitive impairment, clinical severity and MRI changes in MELAS syndrome","volume":"44","author":"Kraya","year":"2019","journal-title":"Mitochondrion"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1468-2982.2009.01940.x","article-title":"Migraine and Genetic and Acquired Vasculopathies","volume":"29","author":"Stam","year":"2009","journal-title":"Cephalalgia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/STROKEAHA.119.028170","article-title":"Migraine with Aura as Early Disease Marker in Hereditary Dutch-Type Cerebral Amyloid Angiopathy","volume":"51","author":"Koemans","year":"2020","journal-title":"Stroke"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000121986","article-title":"Increased Prevalence of Significant Recurrent Headache in Preclinical Familial Alzheimer\u2019s Disease Mutation Carriers","volume":"25","author":"Ringman","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/head.12781","article-title":"The Use of Antiepileptics in Migraine Prophylaxis","volume":"56","author":"Bagnato","year":"2016","journal-title":"Headache J. Head Face Pain"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fneur.2018.00019","article-title":"Understanding Spreading Depression from Headache to Sudden Unexpected Death","volume":"9","author":"Cozzolino","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2147\/nedt.2006.2.4.475","article-title":"Psychopharmacology of topiramate: From epilepsy to bipolar disorder","volume":"2","author":"Mula","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fct.2018.05.022","article-title":"Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors","volume":"118","author":"Shalaby","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2017.01.002","article-title":"Mediatory role of NMDA, AMPA\/kainate, GABAA and Alpha2 receptors in topiramate neuroprotective effects against methylphenidate induced neurotoxicity in rat","volume":"179","author":"Motaghinejad","year":"2017","journal-title":"Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.yebeh.2004.06.017","article-title":"Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: Relationships to blood serum levels and comedication","volume":"5","author":"Kockelmann","year":"2004","journal-title":"Epilepsy Behav."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3988\/jcn.2006.2.2.126","article-title":"Cognitive Effects of Low-dose Topiramate Compared with Oxcarbazepine in Epilepsy Patients","volume":"2","author":"Kim","year":"2006","journal-title":"J. Clin. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.yebeh.2005.01.002","article-title":"Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy","volume":"6","author":"Fritz","year":"2005","journal-title":"Epilepsy Behav."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1684\/j.1950-6945.2005.tb00128.x","article-title":"Topiramate: A prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy","volume":"7","author":"Schier","year":"2005","journal-title":"Epileptic Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yebeh.2007.02.007","article-title":"The influence of antiepileptic drugs on cognition: A comparison of levetiracetam with topiramate","volume":"10","author":"Gomer","year":"2007","journal-title":"Epilepsy Behav."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.clinph.2010.03.013","article-title":"Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials","volume":"121","author":"Jung","year":"2010","journal-title":"Clin. Neurophysiol."},{"key":"ref_51","first-page":"17","article-title":"Topiramate in the prevention and treatment of migraine: Efficacy, safety and patient preference","volume":"6","author":"Naegel","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/2042098612455357","article-title":"Topiramate and cognitive impairment: Evidence and clinical implications","volume":"3","author":"Mula","year":"2012","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.yebeh.2007.09.001","article-title":"Topiramate in children and adolescents with epilepsy and mental retardation: A prospective study on behavior and cognitive effects","volume":"12","author":"Coppola","year":"2008","journal-title":"Epilepsy Behav."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.yebeh.2003.07.007","article-title":"A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events","volume":"4","author":"Kanner","year":"2003","journal-title":"Epilepsy Behav."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000003736","article-title":"Effect of topiramate and zonisamide on fMRI cognitive networks","volume":"88","author":"Wandschneider","year":"2017","journal-title":"Neurology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: A commentatory","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem. Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1212\/01.WNL.0000063308.22506.19","article-title":"Differential cognitive and behavioral effects of topiramate and valproate","volume":"60","author":"Meador","year":"2003","journal-title":"Neurology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/archneur.1996.00550100086018","article-title":"Effect of Valproate on Cognitive Functioning","volume":"53","author":"Prevey","year":"1996","journal-title":"Arch. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/j.1528-1167.2006.00711.x","article-title":"The Frequency of Reversible Parkinsonism and Cognitive Decline Associated with Valproate Treatment: A Study of 364 Patients with Different Types of Epilepsy","volume":"47","year":"2006","journal-title":"Epilepsia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00806585","article-title":"Chronic administration of valproic acid induces a decrease in rat striatal glutamate and taurine levels","volume":"10","author":"Acosta","year":"1996","journal-title":"Amino Acids"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12035-014-8751-4","article-title":"Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-\u03b2 Deposition in Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"51","author":"Xuan","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.semcdb.2006.09.003","article-title":"\u03b12\u03b4 and the mechanism of action of gabapentin in the treatment of pain","volume":"17","author":"Maneuf","year":"2006","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(99)00006-6","article-title":"Cognitive abilities and adjustment with gabapentin: Results of a multisite study","volume":"35","author":"Dodrill","year":"1999","journal-title":"Epilepsy Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1528-1157.1999.tb00858.x","article-title":"Differential Cognitive Effects of Carbamazepine and Gabapentin","volume":"40","author":"Meador","year":"1999","journal-title":"Epilepsia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jnnp.62.4.372","article-title":"Gabapentin and cognition: A double blind, dose ranging, placebo controlled study in refractory epilepsy","volume":"62","author":"Leach","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1528-1157.2002.22501.x","article-title":"Effects of Gabapentin and Carbamazepine on the EEG and Cognition in Healthy Volunteers","volume":"43","author":"Salinsky","year":"2002","journal-title":"Epilepsia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41394-018-0038-y","article-title":"Adverse cognitive effect of gabapentin in individuals with spinal cord injury: Preliminary findings","volume":"4","author":"Shem","year":"2018","journal-title":"Spinal Cord Ser. Cases"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jnen\/nly119","article-title":"Neuroprotective Effects of Gabapentin Against Cerebral Ischemia Reperfusion-Induced Neuronal Autophagic Injury via Regulation of the PI3K\/Akt\/mTOR Signaling Pathways","volume":"78","author":"Yan","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: The calcium channel \u03b12\u2013\u03b4 (alpha2\u2013delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1073\/pnas.1614447114","article-title":"In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures","volume":"114","author":"Cain","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1212\/WNL.0b013e3181d25b34","article-title":"Cognitive effects of pregabalin in healthy volunteers: A double-blind, placebo-controlled trial","volume":"74","author":"Salinsky","year":"2010","journal-title":"Neurology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13340-020-00476-0","article-title":"Protective effect of pregabalin on the brain tissue of diabetic rats","volume":"12","author":"Demir","year":"2021","journal-title":"Diabetol. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567205018666210713125333","article-title":"Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice","volume":"18","author":"Sadleir","year":"2021","journal-title":"Curr. Alzheimer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1034\/j.1600-0404.2000.102002081.x","article-title":"Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy","volume":"102","author":"Placidi","year":"2000","journal-title":"Acta Neurol. Scand."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2165\/00003495-200363190-00009","article-title":"Lamotrigine","volume":"63","author":"Goldsmith","year":"2003","journal-title":"Drugs"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.neurobiolaging.2014.06.009","article-title":"Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP\/PS1 transgenic mice","volume":"35","author":"Zhang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.yebeh.2006.07.011","article-title":"Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: A comparative short-term study","volume":"9","author":"Ciesielski","year":"2006","journal-title":"Epilepsy Behav."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1684\/epd.2008.0227","article-title":"Effect of levetiracetam on cognitive functions and quality of life: A one-year follow-up study","volume":"10","year":"2008","journal-title":"Epileptic Disord."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/WNR.0000000000000601","article-title":"Levetiracetam inhibits oligomeric A\u03b2-induced glutamate release from human astrocytes","volume":"27","author":"Zhang","year":"2016","journal-title":"Neuroreport"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3988\/jcn.2007.3.4.175","article-title":"Long-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients","volume":"3","author":"Park","year":"2007","journal-title":"J. Clin. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnagi.2020.00192","article-title":"Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus","volume":"12","author":"He","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref_82","unstructured":"Thour, A., and Marwaha, R. (2022). Amitriptyline, StatPearls Publishing."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13311-018-0621-8","article-title":"Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action","volume":"15","author":"Sprenger","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2010.04.016","article-title":"Amitriptyline inhibits currents and decreases the mRNA expression of voltage-gated sodium channels in cultured rat cortical neurons","volume":"1336","author":"Yan","year":"2010","journal-title":"Brain Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1213\/ANE.0000000000002352","article-title":"Repeated Administration of Amitriptyline in Neuropathic Pain","volume":"125","author":"Hiroki","year":"2017","journal-title":"Anesth. Analg."},{"key":"ref_86","first-page":"2168","article-title":"Re: A Systematic Review of Amnestic and Non-Amnestic Mild Cognitive Impairment Induced by Anticholinergic, Antihistamine, GABAergic and Opioid Drugs","volume":"190","author":"Wein","year":"2013","journal-title":"J. Urol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Pfistermeister, B., T\u00fcmena, T., Ga\u00dfmann, K.G., Maas, R., and Fromm, M.F. (2017). Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171353"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/ene.15251","article-title":"Anticholinergic drugs and forebrain magnetic resonance imaging changes in cognitively normal people and those with mild cognitive impairment","volume":"29","author":"Meng","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjp.0702994","article-title":"Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine","volume":"129","author":"Okamura","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.chembiol.2009.05.010","article-title":"Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA\/TrkB Heterodimerization and Has Potent Neurotrophic Activity","volume":"16","author":"Jang","year":"2009","journal-title":"Chem. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuroscience.2016.06.040","article-title":"Imipramine and amitriptyline ameliorate the rotenone model of Parkinson\u2019s disease in rats","volume":"332","author":"Kandil","year":"2016","journal-title":"Neuroscience"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1176\/jnp.2010.22.2.130","article-title":"Psychopharmacological neuroprotection in neurodegenerative disease: Heuristic clinical applications","volume":"22","author":"Lauterbach","year":"2010","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11940-019-0557-2","article-title":"Antidepressants for Preventive Treatment of Migraine","volume":"21","author":"Burch","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.archger.2007.05.005","article-title":"Effectiveness and safety of venlafaxine extended release in elderly depressed patients","volume":"46","author":"Ibor","year":"2008","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2217\/pgs-2019-0031","article-title":"Venlafaxine pharmacogenetics: A comprehensive review","volume":"20","author":"Machowska","year":"2019","journal-title":"Pharmacogenomics"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"107151","DOI":"10.1016\/j.clineuro.2022.107151","article-title":"Venlafaxine can reduce the migraine attacks as well as amitriptyline: A noninferiority randomized trial","volume":"214","author":"Hedayat","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fphar.2019.00332","article-title":"Venlafaxine Improves the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and Neuroinflammation in the Brain","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S2215-0366(16)00012-2","article-title":"Effect of antidepressant treatment on cognitive impairments associated with depression: A randomised longitudinal study","volume":"3","author":"Shilyansky","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jpp\/rgaa003","article-title":"Protective effects of duloxetine against chronic immobilisation stress-induced anxiety, depression, cognitive impairment and neurodegeneration in mice","volume":"73","author":"Meejuru","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12640-020-00216-x","article-title":"Duloxetine-Induced Neural Cell Death and Promoted Neurite Outgrowth in N2a Cells","volume":"38","author":"Gao","year":"2020","journal-title":"Neurotox. Res."},{"key":"ref_101","first-page":"627863","article-title":"Does Duloxetine Improve Cognitive Function Independently of Its Antidepressant Effect in Patients with Major Depressive Disorder and Subjective Reports of Cognitive Dysfunction?","volume":"2014","author":"Greer","year":"2014","journal-title":"Depress. Res. Treat."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(01)00989-X","article-title":"Fluoxetine increases the content of neurotrophic protein S100\u03b2 in the rat hippocampus","volume":"420","author":"Manev","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-015-9577-1","article-title":"Duality of Antidepressants and Neuroprotectants","volume":"30","author":"Tizabi","year":"2016","journal-title":"Neurotox. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/acschemneuro.8b00160","article-title":"Interactions of Selective Serotonin Reuptake Inhibitors with \u03b2-Amyloid","volume":"10","author":"Tin","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fphar.2016.00389","article-title":"Fluoxetine Prevents A\u03b21-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-\u03b21","volume":"7","author":"Caraci","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/glia.22926","article-title":"Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP\/PS1 mouse model","volume":"64","author":"Qiao","year":"2016","journal-title":"Glia"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JCP.0b013e31802e0002","article-title":"Does Fluoxetine Have Any Effect on the Cognition of Patients with Mild Cognitive Impairment?","volume":"27","author":"Mowla","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e2666","DOI":"10.1212\/WNL.0000000000010733","article-title":"Effect of escitalopram on A\u03b2 levels and plaque load in an Alzheimer mouse model","volume":"95","author":"Cirrito","year":"2020","journal-title":"Neurology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0269881106072506","article-title":"Selective verbal and spatial memory impairment after 5-HT 1A and 5-HT 2A receptor blockade in healthy volunteers pre-treated with an SSRI","volume":"21","author":"Wingen","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/ana.25236","article-title":"Serotonin, \u03b2-amyloid, and cognition in Parkinson disease","volume":"83","author":"Kotagal","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11906-015-0592-7","article-title":"Antihypertensive Therapies and Cognitive Function: A Review","volume":"17","author":"Kherada","year":"2015","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_113","first-page":"CD001841","article-title":"First-line drugs for hypertension","volume":"2018","author":"Wright","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"106649","DOI":"10.1016\/j.vph.2020.106649","article-title":"Beta-blocker therapy and risk of vascular dementia: A population-based prospective study","volume":"125\u2013126","author":"Holm","year":"2020","journal-title":"Vascul. Pharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1176\/appi.neuropsych.11100240","article-title":"Use of Beta-Blockers and Risk of Dementia in Elderly Patients","volume":"24","author":"Fares","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1533317506295889","article-title":"The Influence of \u03b2-Blockers on Delayed Memory Function in People with Cognitive Impairment","volume":"22","author":"Gliebus","year":"2007","journal-title":"Am. J. Alzheimers Dis. Other Dementiasr"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Beaman, E.E., Bonde, A.N., Ulv Larsen, S.M., Ozenne, B., Lohela, T.J., Nedergaard, M., G\u00edslason, G.H., Knudsen, G.M., and Holst, S.C. (2022). Blood\u2013brain barrier permeable \u03b2-blockers linked to lower risk of Alzheimer\u2019s disease in hypertension. Brain, awac076.","DOI":"10.1093\/brain\/awac076"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.podrm.2017.02.006","article-title":"Propranolol","volume":"Volume 42","author":"Bakheit","year":"2017","journal-title":"Profiles of Drug Substances, Excipients and Related Methodology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/npp.2011.307","article-title":"Stimulation of the Noradrenergic System during Memory Formation Impairs Extinction Learning but not the Disruption of Reconsolidation","volume":"37","author":"Soeter","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/15265160701518565","article-title":"Propranolol, Cognitive Biases, and Practical Decision-Making","volume":"7","author":"Craigie","year":"2007","journal-title":"Am. J. Bioeth."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0269881105048888","article-title":"Noradrenergic blockade and numeric working memory in humans","volume":"19","author":"Mottweiler","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF02600398","article-title":"Cognitive function in hypertensives treated with atenolol or propranolol","volume":"5","author":"Palac","year":"1990","journal-title":"J. Gen. Intern. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.HYP.11.5.470","article-title":"Effects of beta-blockade and exercise on cardiovascular and cognitive functioning","volume":"11","author":"Madden","year":"1988","journal-title":"Hypertension"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(00)00304-1","article-title":"The effects of propranolol on cognitive function and quality of life: A randomized trial among patients with diastolic hypertension","volume":"108","author":"Halliday","year":"2000","journal-title":"Am. J. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.neuroscience.2006.06.056","article-title":"Amyloid beta-protein1-42 increases cAMP and apolipoprotein E levels which are inhibited by \u03b21 and \u03b22-adrenergic receptor antagonists in mouse primary astrocytes","volume":"142","author":"Igbavboa","year":"2006","journal-title":"Neuroscience"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s10194-019-1060-6","article-title":"Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine","volume":"20","author":"Kouremenos","year":"2019","journal-title":"J. Headache Pain"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.1988.03720130040027","article-title":"Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study","volume":"259","author":"Wikstrand","year":"1988","journal-title":"JAMA"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0002-8703(88)90106-8","article-title":"Impact of \u03b2-blockade on complex cognitive functioning","volume":"116","author":"Streufert","year":"1988","journal-title":"Am. Heart J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"105089","DOI":"10.1016\/j.nbd.2020.105089","article-title":"Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer\u2019s Disease","volume":"146","author":"Evans","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2165\/00003495-199142030-00007","article-title":"Atenolol","volume":"42","author":"Wadworth","year":"1991","journal-title":"Drugs"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0022-3999(92)90087-I","article-title":"Cognitive effects of beta blockers","volume":"36","author":"Dimsdale","year":"1992","journal-title":"J. Psychosom. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.jhh.1001613","article-title":"Influence of losartan and atenolol on memory function in very elderly hypertensive patients","volume":"17","author":"Fogari","year":"2003","journal-title":"J. Hum. Hypertens."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/pgmj.66.782.1050","article-title":"Cognitive impairment associated with beta-blockade in the elderly","volume":"66","author":"Rogers","year":"1990","journal-title":"Postgrad. Med. J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/00004872-200208000-00028","article-title":"Effects of six anti-hypertensive medications on cognitive performance","volume":"20","author":"Muldoon","year":"2002","journal-title":"J. Hypertens."},{"key":"ref_135","unstructured":"Bazroon, A.A., and Alrashidi, N.F. (2022). Bisoprolol. StatPearls, StatPearls Publishing."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMcp1605502","article-title":"Migraine","volume":"377","author":"Charles","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.parkreldis.2003.12.004","article-title":"Flunarizine and cinnarizine-induced parkinsonism: A historical and clinical analysis","volume":"10","author":"Teive","year":"2004","journal-title":"Park. Relat. Disord."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3389\/fphar.2019.01495","article-title":"Flunarizine Induced Parkinsonism in Migraine Group: A Nationwide Population-Based Study","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/jcbfm.1995.63","article-title":"D 2 Receptor Blockade by Flunarizine and Cinnarizine Explains Extrapyramidal Side Effects. A SPECT Study","volume":"15","author":"Podreka","year":"1995","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41580-018-0052-8","article-title":"The machineries, regulation and cellular functions of mitochondrial calcium","volume":"19","author":"Giorgi","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of Glutamate and NMDA Receptors in Alzheimer\u2019s Disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"600089","DOI":"10.3389\/fnmol.2020.600089","article-title":"A Neurotoxic M\u00e9nage-\u00e0-trois: Glutamate, Calcium, and Zinc in the Excitotoxic Cascade","volume":"13","author":"Granzotto","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"579953","DOI":"10.3389\/fnins.2020.579953","article-title":"Excitotoxicity: Still Hammering the Ischemic Brain in 2020","volume":"14","author":"Choi","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.expneurol.2009.09.027","article-title":"Glutamate, excitotoxicity, and programmed cell death in parkinson disease","volume":"220","author":"Caudle","year":"2009","journal-title":"Exp. Neurol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1089\/ars.2010.3359","article-title":"Calcium Dysregulation and Homeostasis of Neural Calcium in the Molecular Mechanisms of Neurodegenerative Diseases Provide Multiple Targets for Neuroprotection","volume":"14","author":"Reiser","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s12070-017-1120-7","article-title":"Cinnarizine: A Contemporary Review","volume":"71","author":"Kirtane","year":"2019","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2222.1999.0290s3133.x","article-title":"Antihistamines: Models to assess sedative properties, assessment of sedation, safety and other side-effects","volume":"29","author":"Hindmarch","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e1107","DOI":"10.1038\/tp.2017.56","article-title":"Effects of dopamine D2\/D3 receptor antagonism on human planning and spatial working memory","volume":"7","author":"Naef","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.4475-07.2008","article-title":"Working Memory Capacity Predicts Dopamine Synthesis Capacity in the Human Striatum","volume":"28","author":"Cools","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"12559","DOI":"10.1523\/JNEUROSCI.0626-16.2016","article-title":"Aging Affects Dopaminergic Neural Mechanisms of Cognitive Flexibility","volume":"36","author":"Berry","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e1067","DOI":"10.1542\/peds.2005-2059","article-title":"Pediatric Cinnarizine Overdose and Toxicokinetics","volume":"117","author":"Turner","year":"2006","journal-title":"Pediatrics"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00176487","article-title":"Promethazine, scopolamine and cinnarizine: Comparative time course of psychological performance effects","volume":"92","author":"Parrott","year":"1987","journal-title":"Psychopharmacology"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/026988110101500311","article-title":"The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance","volume":"15","author":"Gordon","year":"2001","journal-title":"J. Psychopharmacol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.pediatrneurol.2014.05.031","article-title":"Efficacy and Safety of Cinnarizine in the Prophylaxis of Migraine in Children: A Double-Blind Placebo-Controlled Randomized Trial","volume":"51","author":"Ashrafi","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"ref_156","first-page":"517","article-title":"Amelioration of the haloperidol-induced memory impairment and brain oxidative stress by cinnarizine","volume":"11","author":"Salem","year":"2012","journal-title":"EXCLI J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-198427010-00002","article-title":"Flunarizine A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use","volume":"27","author":"Holmes","year":"1984","journal-title":"Drugs"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1468-2982.2003.00705.x","article-title":"Flunarizine Effects on Oxidative Stress in Migraine Patients","volume":"24","author":"Ciancarelli","year":"2004","journal-title":"Cephalalgia"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10565-006-0037-9","article-title":"A calcium channel blocker flunarizine attenuates the neurotoxic effects of iron","volume":"22","author":"Bostanci","year":"2006","journal-title":"Cell Biol. Toxicol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0014-2999(91)90858-N","article-title":"Antioxidant effect of calcium antagonists on microsomai membranes isolated from different brain areas","volume":"204","author":"Goncalves","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0006-2952(99)00068-4","article-title":"Reversal by flunarizine of the decrease in hippocampal acetylcholine release in pentylenetetrazole-kindled rats","volume":"58","author":"Serra","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0306-3623(90)90830-F","article-title":"Effects of the Ca2+-antagonists nifedipine, verapamil, flunarizine and of the calmodulin antagonist trifluoperazine on muscarinic cholinergic receptors in rat cerebral cortex","volume":"21","author":"Popova","year":"1990","journal-title":"Gen. Pharmacol. Vasc. Syst."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pbb.2015.01.015","article-title":"Investigation of the role of non-selective calcium channel blocker (flunarizine) on cerebral ischemic\u2013reperfusion associated cognitive dysfunction in aged mice","volume":"131","author":"Gulati","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00005344-199118081-00008","article-title":"Flunarizine in migraine prophylaxis: The clinical experience","volume":"18","author":"Schmidt","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1528-1167.2012.03623.x","article-title":"A randomized controlled trial of flunarizine as add-on therapy and effect on cognitive outcome in children with infantile spasms","volume":"53","author":"Bitton","year":"2012","journal-title":"Epilepsia"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"R498","DOI":"10.1152\/ajpregu.00190.2003","article-title":"Physiological genomic analysis of the brain renin-angiotensin system","volume":"285","author":"Davisson","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cns.12802","article-title":"Candesartan ameliorates brain inflammation associated with Alzheimer\u2019s disease","volume":"24","author":"Torika","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10571-015-0327-y","article-title":"Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer\u2019s Disease","volume":"36","author":"Saavedra","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/jgs.13627","article-title":"Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer\u2019s Disease","volume":"63","author":"Wharton","year":"2015","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Barthold, D., Joyce, G., Wharton, W., Kehoe, P., and Zissimopoulos, J. (2018). The association of multiple anti-hypertensive medication classes with Alzheimer\u2019s disease incidence across sex, race, and ethnicity. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206705"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/01.hjh.0000220419.86149.11","article-title":"Involvement of the renin\u2013angiotensin system in migraine","volume":"24","author":"Tronvik","year":"2006","journal-title":"J. Hypertens."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator\u2013Activated Receptor-\u03b3 Activity","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12974-018-1262-x","article-title":"RAS modulation prevents progressive cognitive impairment after experimental stroke: A randomized, blinded preclinical trial","volume":"15","author":"Ahmed","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/HYPERTENSIONAHA.118.11775","article-title":"Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease","volume":"72","author":"Trigiani","year":"2018","journal-title":"Hypertension"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE)","volume":"21","author":"Lithell","year":"2003","journal-title":"J. Hypertens."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/01.wnl.0000311447.85948.78","article-title":"Candesartan and cognitive decline in older patients with hypertension: A substudy of the SCOPE trial","volume":"70","author":"Saxby","year":"2008","journal-title":"Neurology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e1435","DOI":"10.1212\/WNL.0000000000007174","article-title":"Effects of blood pressure and lipid lowering on cognition","volume":"92","author":"Bosch","year":"2019","journal-title":"Neurology"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jgs.12100","article-title":"Antihypertensive Therapy and Cerebral Hemodynamics in Executive Mild Cognitive Impairment: Results of a Pilot Randomized Clinical Trial","volume":"61","author":"Hajjar","year":"2013","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"e2012252","DOI":"10.1001\/jamanetworkopen.2020.12252","article-title":"Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive Impairment","volume":"3","author":"Hajjar","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_180","unstructured":"(2022, June 15). Candesartan\u2019s Effects on Alzheimer\u2019s Disease and Related Biomarkers (CEDAR), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02646982."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin Gene-Related Peptide: Physiology and Pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","article-title":"The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine","volume":"158","author":"Iyengar","year":"2017","journal-title":"Pain"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.bjp.0705807","article-title":"Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat","volume":"142","author":"Storer","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s10194-017-0741-2","article-title":"Calcitonin gene-related peptide and pain: A systematic review","volume":"18","author":"Schou","year":"2017","journal-title":"J. Headache Pain"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s10194-021-01335-2","article-title":"CGRP monoclonal antibodies in migraine: An efficacy and tolerability comparison with standard prophylactic drugs","volume":"22","author":"Vandervorst","year":"2021","journal-title":"J. Headache Pain"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Papiri, G., Vignini, A., Capriotti, L., Verdenelli, P., Alia, S., Di Paolo, A., Fiori, C., Baldinelli, S., Silvestrini, M., and Luzzi, S. (2022). Cerebrospinal Fluid \u03b1-Calcitonin Gene-Related Peptide: A Comparison between Alzheimer\u2019s Disease and Multiple Sclerosis. Biomolecules, 12.","DOI":"10.3390\/biom12020199"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1097-4547(19961101)46:3<316::AID-JNR4>3.0.CO;2-N","article-title":"The psychotomimetic drugs D-amphetamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the rat","volume":"46","author":"Hertel","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0031-9384(95)00066-R","article-title":"Effects of CGRP on active avoidance behavior in rats","volume":"58","author":"Telegdy","year":"1995","journal-title":"Physiol. Behav."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jnutbio.2010.09.016","article-title":"Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus","volume":"22","author":"Harada","year":"2011","journal-title":"J. Nutr. Biochem."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuropharm.2009.12.008","article-title":"Cilostazol improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus","volume":"58","author":"Zhao","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.trsl.2009.05.001","article-title":"Stimulation of sensory neurons improves cognitive function by promoting the hippocampal production of insulin-like growth factor-I in mice","volume":"154","author":"Harada","year":"2009","journal-title":"Transl. Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.108.147280","article-title":"Donepezil Improves Cognitive Function in Mice by Increasing the Production of Insulin-Like Growth Factor-I in the Hippocampus","volume":"330","author":"Narimatsu","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2018.07.005","article-title":"Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitis","volume":"323","author":"Rossetti","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/HJH.0000000000001649","article-title":"Endogenous calcitonin gene-related peptide suppresses ischemic brain injuries and progression of cognitive decline","volume":"36","author":"Zhai","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bph.14075","article-title":"Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR Review 25","volume":"175","author":"Hay","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JAD-160677","article-title":"Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer\u2019s Disease Mouse Model","volume":"56","author":"Wang","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"108017","DOI":"10.1016\/j.neuropharm.2020.108017","article-title":"Characterization of the effects of calcitonin gene-related peptide receptor antagonist for Alzheimer\u2019s disease","volume":"168","author":"Na","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0074-7742(04)59009-8","article-title":"Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: Implications for human behavior pathologies","volume":"59","author":"Fiore","year":"2004","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/head.13591","article-title":"CGRP and Brain Functioning: Cautions for Migraine Treatment","volume":"59","author":"Borkum","year":"2019","journal-title":"Headache"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/neu.2018.31","article-title":"CGRP in a gene-environment interaction model for depression: Effects of antidepressant treatment","volume":"31","author":"Angelucci","year":"2019","journal-title":"Acta Neuropsychiatr."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","article-title":"Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine","volume":"81","author":"Larrosa","year":"2013","journal-title":"Neurology"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0972-2327.182302","article-title":"Understanding migraine: Potential role of neurogenic inflammation","volume":"19","author":"Malhotra","year":"2016","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s10194-017-0811-5","article-title":"Triptans and CGRP blockade-impact on the cranial vasculature","volume":"18","author":"Benemei","year":"2017","journal-title":"J. Headache Pain"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/0333102417736900","article-title":"Recognizing the role of CGRP and CGRP receptors in migraine and its treatment","volume":"39","author":"Edvinsson","year":"2019","journal-title":"Cephalalgia"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archneur.59.7.1084","article-title":"Mechanisms of Action of the 5-HT 1B\/1D Receptor Agonists","volume":"59","author":"Tepper","year":"2002","journal-title":"Arch. Neurol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10194-009-0170-y","article-title":"Does sumatriptan cross the blood\u2013brain barrier in animals and man?","volume":"11","year":"2010","journal-title":"J. Headache Pain"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaneurol.2019.0755","article-title":"Association between Sumatriptan Treatment during a Migraine Attack and Central 5-HT 1B Receptor Binding","volume":"76","author":"Deen","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"aay5947","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Zhong","year":"2020","journal-title":"Science"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1523\/JNEUROSCI.19-20-09063.1999","article-title":"Ventromedial Thalamic Neurons Convey Nociceptive Signals from the Whole Body Surface to the Dorsolateral Neocortex","volume":"19","author":"Monconduit","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/s41467-018-04497-x","article-title":"Regulation of cortical activity and arousal by the matrix cells of the ventromedial thalamic nucleus","volume":"9","author":"Honjoh","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/ejn.14215","article-title":"Thalamic afferents to prefrontal cortices from ventral motor nuclei in decision-making","volume":"49","author":"Sieveritz","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.npp.1300330","article-title":"Differential Involvement of 5-HT1B\/1D and 5-HT6 Receptors in Cognitive and Non-cognitive Symptoms in Alzheimer\u2019s Disease","volume":"29","author":"Hirst","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1073\/pnas.97.1.506","article-title":"Prefrontal cortex and episodic memory retrieval mode","volume":"97","author":"Lepage","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0014-2999(86)90443-7","article-title":"Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release","volume":"129","author":"Maura","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/157340005774575073","article-title":"Involvement of the Serotonergic System in Cognitive and Behavioral Symptoms of Alzheimers Disease","volume":"1","author":"Ramirez","year":"2005","journal-title":"Curr. Psychiatry Rev."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1073\/pnas.1524183113","article-title":"Opposing roles for serotonin in cholinergic neurons of the ventral and dorsal striatum","volume":"113","author":"Virk","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0166-4328(97)00055-7","article-title":"Effects of the 5-HT receptor antagonists GR127935 (5-HT1B\/1D) and MDL100907 (5-HT2A) in the consolidation of learning","volume":"89","author":"Meneses","year":"1997","journal-title":"Behav. Brain Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1568026023393903","article-title":"Recent advances in 5-HT1B\/1D receptor antagonists and agonists and their potential therapeutic applications","volume":"2","author":"Slassi","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neures.2017.03.011","article-title":"Interaction between harmane, a class of \u03b2-carboline alkaloids, and the CA1 serotonergic system in modulation of memory acquisition","volume":"122","author":"Nasehi","year":"2017","journal-title":"Neurosci. Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pbb.2014.08.007","article-title":"Possible involvement of CA1 5-HT1B\/1D and 5-HT2A\/2B\/2C receptors in harmaline-induced amnesia","volume":"125","author":"Nasehi","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/sj.npp.1300235","article-title":"Analysis of the Role of the 5-HT1B Receptor in Spatial and Aversive Learning in the Rat","volume":"28","author":"Madjid","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref_222","unstructured":"FDA (2022, August 07). Access.Data.FDA.gov Rizatriptan 2011, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020864s011s016s017s018s019,020865s012s016s018s020s021lbl.pdf."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000512602","article-title":"Prevalence of Mimics and Severe Comorbidity in Patients with Clinically Suspected Transient Global Amnesia","volume":"50","author":"Werner","year":"2021","journal-title":"Cerebrovasc. Dis."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1526-4610.2000.00049.x","article-title":"Transient Global Amnesia, Migraine, Thalamic Infarct, Dihydroergotamine, and Sumatriptan","volume":"40","author":"Pradalier","year":"2000","journal-title":"Headache J. Head Face Pain"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0149-7634(01)00007-0","article-title":"Could the 5-HT1B receptor inverse agonism affect learning consolidation?","volume":"25","author":"Meneses","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pbb.2013.01.019","article-title":"Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats","volume":"105","author":"Montezinho","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1526-4610.2001.111006377.x","article-title":"Sumatriptan Nasal Spray and Cognitive Function During Migraine: Results of an Open-Label Study","volume":"41","author":"Farmer","year":"2001","journal-title":"Headache J. Head Face Pain"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s10194-020-01132-3","article-title":"Lasmiditan mechanism of action\u2014Review of a selective 5-HT1F agonist","volume":"21","author":"Clemow","year":"2020","journal-title":"J. Headache Pain"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s10194-020-01138-x","article-title":"Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: A systematic review and meta-analysis","volume":"21","author":"Hou","year":"2020","journal-title":"J. Headache Pain"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13311-018-0615-6","article-title":"Targeted 5-HT(1F) Therapies for Migraine","volume":"15","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/123.1.9","article-title":"Ergotamine in the acute treatment of migraine: A review and European consensus","volume":"123","year":"2000","journal-title":"Brain"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1046\/j.1526-4610.2003.03213.x","article-title":"Impact of Antimigraine Compounds on Cognitive Processing: A Placebo-Controlled Crossover Study","volume":"43","author":"Evers","year":"2003","journal-title":"Headache J. Head Face Pain"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1468-2982.2000.00067.x","article-title":"The Influence of Ergotamine Abuse on Psychological and Cognitive Functioning","volume":"20","author":"Roon","year":"2000","journal-title":"Cephalalgia"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"16541","DOI":"10.1038\/srep16541","article-title":"The FDA-approved natural product dihydroergocristine reduces the production of the Alzheimer\u2019s disease amyloid-\u03b2 peptides","volume":"5","author":"Lei","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.neurobiolaging.2005.03.006","article-title":"Plasma amyloid \u03b2 protein 42 in non-demented persons aged 75 years: Effects of concomitant medication and medial temporal lobe atrophy","volume":"26","author":"Blasko","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/ph3061966","article-title":"NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data","volume":"3","author":"Pardutz","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jchemneu.2011.06.007","article-title":"Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer\u2019s disease","volume":"42","author":"Blalock","year":"2011","journal-title":"J. Chem. Neuroanat."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3233\/JAD-170205","article-title":"Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer\u2019s Disease Patients","volume":"66","author":"Leandro","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"9027484","DOI":"10.1155\/2016\/9027484","article-title":"Mean Daily Dosage of Aspirin and the Risk of Incident Alzheimer\u2019s Dementia in Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study in Taiwan","volume":"2016","author":"Chang","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jalz.2011.03.012","article-title":"Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer\u2019s disease","volume":"8","author":"Carmichael","year":"2012","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"31466","DOI":"10.1074\/jbc.M201308200","article-title":"Non-steroidal Anti-inflammatory Drugs Stimulate Secretion of Non-amyloidogenic Precursor Protein","volume":"277","author":"Avramovich","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI18162","article-title":"NSAIDs and enantiomers of flurbiprofen target \u03b3-secretase and lower A\u03b242 in vivo","volume":"112","author":"Eriksen","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/156802608783334042","article-title":"Possible mechanisms of action of NSAIDs and related compounds that modulate gamma-secretase cleavage","volume":"8","author":"Kukar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.neuropharm.2005.07.004","article-title":"Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer\u2019s beta-amyloid fibrils in vitro","volume":"49","author":"Hirohata","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/WAD.0000000000000098","article-title":"NSAID Use and Incident Cognitive Impairment in a Population-based Cohort","volume":"30","author":"Wichmann","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.neurobiolaging.2011.09.038","article-title":"Steroid and nonsteroidal anti-inflammatory drugs, cognitive decline, and dementia","volume":"33","author":"Ancelin","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/WNL.0b013e3181a18691","article-title":"Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort","volume":"72","author":"Breitner","year":"2009","journal-title":"Neurology"},{"key":"ref_248","unstructured":"(2022, September 07). Practical Neurology FDA Greenlights Phase 3 Study of Rofecoxib for Acute Treatment of Migraine. Available online: https:\/\/practicalneurology.com\/news\/fda-greenlights-phase-3-study-of-rofecoxib-for-acute-treatment-of-migraine."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/STROKEAHA.107.508549","article-title":"Nonaspirin NSAIDs, Cyclooxygenase 2 Inhibitors, and the Risk for Stroke","volume":"39","author":"Roumie","year":"2008","journal-title":"Stroke"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s10194-021-01365-w","article-title":"Brain barriers and their potential role in migraine pathophysiology","volume":"23","author":"Wiggers","year":"2022","journal-title":"J. Headache Pain"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abb8739","article-title":"Glymphatic failure as a final common pathway to dementia","volume":"370","author":"Nedergaard","year":"2020","journal-title":"Science"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"e2631","DOI":"10.1002\/brb3.2631","article-title":"Glymphatic system dysfunction in patients with cluster headache","volume":"12","author":"Kim","year":"2022","journal-title":"Brain Behav."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/pm\/pnab137","article-title":"The Potential Role of the Glymphatic System in Headache Disorders","volume":"22","author":"Toriello","year":"2021","journal-title":"Pain Med."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1523\/JNEUROSCI.3390-16.2017","article-title":"Cortical Spreading Depression Closes Paravascular Space and Impairs Glymphatic Flow: Implications for Migraine Headache","volume":"37","author":"Schain","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"e20211275","DOI":"10.1084\/jem.20211275","article-title":"Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration","volume":"219","author":"Ishida","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molmed.2019.11.008","article-title":"Glymphatic System Impairment in Alzheimer\u2019s Disease and Idiopathic Normal Pressure Hydrocephalus","volume":"26","author":"Reeves","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"655052","DOI":"10.3389\/fphar.2021.655052","article-title":"CNS-Draining Meningeal Lymphatic Vasculature: Roles, Conundrums and Future Challenges","volume":"12","author":"Delivanoglou","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Mikhailov, N., Koroleva, K., Abdollahzadeh, A., Giniatullina, R., Gafurov, O., Malm, T., Sierra, A., Tohka, J., Noe, F., and Giniatullin, R. (2020). The role of the meningeal lymphatic system in local inflammation and trigeminal nociception implicated in migraine pain. bioRxiv.","DOI":"10.1101\/2020.04.25.060939"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuron.2018.09.022","article-title":"The Meningeal Lymphatic System: A New Player in Neurophysiology","volume":"100","author":"Fu","year":"2018","journal-title":"Neuron"},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Li, T., Lu, L., Pember, E., Li, X., Zhang, B., and Zhu, Z. (2022). New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer\u2019s Disease and Its Potential for Therapeutic Intervention. Cells, 11.","DOI":"10.3390\/cells11121925"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/brain\/awu155","article-title":"Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration","volume":"137","author":"Suzzi","year":"2014","journal-title":"Brain"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11418\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:40:48Z","timestamp":1760143248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":263,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijms231911418"],"URL":"https:\/\/doi.org\/10.3390\/ijms231911418","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}